Molecular and Cellular Biology, November 1998, p. 6525-6537, Vol. 18, No. 11
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Graduate Program in Genetics and Molecular Biology and Department of Biology, Emory University, Atlanta, Georgia 30322
Received 22 June 1998/Returned for modification 5 August 1998/Accepted 19 August 1998
| |
ABSTRACT |
|---|
|
|
|---|
Mismatch repair (MMR) proteins actively inhibit recombination between diverged sequences in both prokaryotes and eukaryotes. Although the molecular basis of the antirecombination activity exerted by MMR proteins is unclear, it presumably involves the recognition of mismatches present in heteroduplex recombination intermediates. This recognition could be exerted during the initial stage of strand exchange, during the extension of heteroduplex DNA, or during the resolution of recombination intermediates. We previously used an assay system based on 350-bp inverted-repeat substrates to demonstrate that MMR proteins strongly inhibit mitotic recombination between diverged sequences in Saccharomyces cerevisiae. The assay system detects only those events that reverse the orientation of the region between the recombination substrates, which can occur as a result of either intrachromatid crossover or sister chromatid conversion. In the present study we sequenced the products of mitotic recombination between 94%-identical substrates in order to map gene conversion tracts in wild-type versus MMR-defective yeast strains. The sequence data indicate that (i) most recombination occurs via sister chromatid conversion and (ii) gene conversion tracts in an MMR-defective strain are significantly longer than those in an isogenic wild-type strain. The shortening of conversion tracts observed in a wild-type strain relative to an MMR-defective strain suggests that at least part of the antirecombination activity of MMR proteins derives from the blockage of heteroduplex extension in the presence of mismatches.
| |
INTRODUCTION |
|---|
|
|
|---|
Homologous recombination events can be either reciprocal or nonreciprocal in nature. Reciprocal recombination (crossing over) alters the linkage relationships of loci that flank the site of an exchange, whereas nonreciprocal recombination (gene conversion) is defined as the unidirectional transfer of information from one DNA molecule to another. All present models of recombination stipulate the formation of a heteroduplex recombination intermediate, which is formed by complementary base pairing of single strands derived from different duplexes. Correction of a mismatch in heteroduplex DNA can result in a gene conversion event, and such correction is effected by the same mismatch repair (MMR) machinery that corrects errors made during DNA replication. Cocorrection of a series of contiguous mismatches generates a conversion tract, the length of which is considered to be a minimal estimate of the extent of the heteroduplex intermediate formed. The point at which the recombining molecules exchange single strands to form heteroduplex DNA is referred to as a Holliday junction, and cleavage of this junction gives rise to crossovers and noncrossovers at roughly equivalent frequencies.
Homologous recombination usually involves allelic sequences on homologous chromosomes but also can occur between dispersed (ectopic) repeated sequences. Ectopic gene conversion provides a mechanism for homogenizing repeated sequences and hence is important in the concerted evolution of multigene families. In contrast to the relatively benign effects of ectopic gene conversion, ectopic crossing over results in various types of chromosome rearrangements which destabilize overall genome structure. Given the large amount of repetitive DNA present in the genomes of higher eukaryotes and the potentially deleterious nature of ectopic interactions, one would predict that allelic interactions should be highly favored over ectopic interactions. Two features of repeated sequences that might be important in limiting ectopic recombination are the length of the repeats and the degree of sequence identity between the repeats (38).
Studies with bacterial species (1, 22, 28, 29, 39, 46, 51, 57-59), Saccharomyces cerevisiae (4, 7, 12, 13, 20, 24, 30, 32, 33, 35, 36, 40, 43, 44), and higher eukaryotes (14, 15, 52, 56) have uniformly found that sequence divergence acts as a potent barrier to recombination. As first shown in conjugational crosses between Escherichia coli and Salmonella typhimurium (39), much of the recombination barrier associated with sequence divergence in prokaryotes derives from the action of the MMR machinery (1, 16, 22, 28, 29, 51, 57). The MMR system of E. coli (31) is used as a paradigm for eukaryotic MMR, and homologs of the bacterial MutS protein, which binds mismatched base pairs, and of the MutL protein, which interacts with MutS, have been identified in eukaryotes (11). In E. coli, elimination of either MutS or MutL results in a comparable increase in recombination between diverged sequences (1, 39). The antirecombination activity of MMR proteins also has been documented in yeast (7, 12, 13, 24, 32, 43, 44) and mammalian cells (9, 14), indicating that the barrier to recombination imposed by the MMR system is evolutionarily conserved. Interestingly, however, the antirecombination activities of yeast MutS and MutL homologs (Msh2p and Pms1p, respectively) are not equivalent. In yeast, elimination of Msh2p elevates recombination between diverged sequences to a greater extent than does elimination of Pms1p (references 12 and 44 and unpublished data), indicating that the antirecombination effect of Msh2p is not totally dependent on Pms1p. This observation is consistent with in vitro DNA binding studies demonstrating that the yeast MutL homologs increase the mismatch binding efficiency of the MutS homologs (19).
Systematic studies carried out with bacterial cells (28, 51) and yeast (13) have revealed a log-linear relationship between the rate of recombination and the degree of sequence divergence in both MMR-competent and MMR-defective cells. Such a relationship is predicted by models that assume that a minimal length of perfect homology (the "MEPS" [45]) is necessary to initiate recombination; the number of MEPS decreases exponentially with sequence divergence. In the yeast experiments, a single mismatch within a 350-bp substrate was sufficient to reduce recombination fourfold, and this inhibition was completely dependent on the MMR machinery (13). Additional mismatches had a cumulative negative effect on recombination; some of the inhibition was due to MMR-associated antirecombination activity, and some resulted from an MMR-independent process. The MMR-independent inhibition of recombination was attributed to an inability of the recombination machinery to recombine diverged sequences efficiently.
The antirecombination activity of MMR proteins presumably derives from the recognition of mismatches in heteroduplex recombination intermediates, but how this impairs recombination is unclear. Because of the strand-nicking activity associated with the repair of replication errors in E. coli, a heteroduplex destruction model has been considered. According to this model, the attempted repair of multiple mismatches in close proximity would create convergent excision tracts and hence double-strand breaks, which would destroy the recombination intermediate (see reference 6). The efficiencies of transformation of highly mismatched heteroduplex molecules into MMR-competent versus MMR-defective E. coli are similar, however, and this finding is not consistent with the destruction of mismatched heteroduplex DNA (53). Also, there is no evidence of MMR-associated strand nicking in eukaryotes, and such nicking would be a prerequisite for heteroduplex destruction. A second model that has been proposed is the heteroduplex rejection model, which posits that MMR proteins modulate the formation of mismatch-containing heteroduplex DNA (3, 10, 57). One possibility is that MMR-associated helicase activity unwinds mismatch-containing heteroduplex DNA, thus resulting in rejection of the donor strand (10, 57). Alternatively, the MMR machinery might interact directly with the recombination machinery to cause either reverse branch migration or immediate resolution of a recombination intermediate when mismatched heteroduplex is detected (3). A specific prediction of heteroduplex rejection models is that the extent of heteroduplex DNA should be longer in MMR-defective cells than in wild-type cells. Consistent with such a model, Worth et al. (55) have demonstrated that both the rate and the extent of in vitro RecA-catalyzed heteroduplex formation were reduced in the presence of purified MutS and MutL proteins.
One approach to understanding the molecular basis of MMR-associated antirecombination activity is to ask whether recombination products in MMR-competent cells differ significantly from those in MMR-defective cells. Several parameters can be examined in experiments of this sort. One can, for example, examine the ratio of gene conversions to crossovers in order to determine if the MMR machinery biases the resolution of recombination intermediates in a mismatch-dependent manner (see, e.g., reference 5). Alternatively, comparison of gene conversion tracts in MMR-competent and MMR-defective cells will indicate whether the molecular nature of recombination intermediates is impacted by the MMR machinery. The endpoints of the conversion tracts can be examined, or the lengths of the tracts can be determined. A difference in the endpoints of conversion tracts between MMR-competent and MMR-defective cells would imply a role of the MMR machinery in determining preferential sites of recombination initiation and/or resolution; a difference in the lengths of conversion tracts would imply a role for the MMR machinery in monitoring the fidelity of base pairing during heteroduplex formation.
In the present study, we have used an intron-based inverted-repeat (IR) assay system to characterize mitotic gene conversion tracts in wild-type versus MMR-defective yeast strains. With the intron-based system, one selects specifically for events that reverse the orientation of the region between the recombination substrates; reorientation of this region (the invertible segment) can result from either intrachromatid crossover or sister chromatid conversion. Using 94%-identical substrates, we have found an MMR-dependent conversion gradient across the substrates, with an excess of conversion tract endpoints in identity intervals closest to the invertible segment in MMR-competent cells. Such clustering is most easily explained by assuming that recombination occurs predominantly through a sister chromatid conversion mechanism rather than via intrachromatid crossover. Conversion tract length calculations based on an unequal sister chromatid conversion model indicate that conversion tracts are significantly longer in MMR-defective cells than in wild-type cells. The relevance of the MMR-dependent shortening of conversion tracts to the antirecombination activity of MMR proteins is discussed.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmid constructions.
Plasmids with various chicken
-tubulin isoform 2 cDNA sequences (c
2 sequences) were constructed
according to the general scheme outlined in Fig.
1 (see references 12
and 13 for more details). 5' and 3' cassettes were
derived by replacing sequences in pSR266 (the basic
HIS3::intron construct) with PCR-amplified c
2
sequences. To construct plasmids pSR424, pSR584, and pSR610, a
SmaI/SpeI restriction fragment containing the 5'
cassette was inserted into a SpeI/NotI-digested
plasmid containing the 3' cassette (the NotI site was filled
in with the Klenow fragment of DNA polymerase). To construct plasmid
pSR612, a SmaI/SpeI restriction fragment containing the 5' cassette was inserted into a NotI-digested
plasmid containing the 3' cassette; the ends of both fragments were
filled in with the Klenow fragment of DNA polymerase.
|
2 (5' cassette) and c
2-21mm (3'
cassette) IR substrates in orientation 1. These substrates have 94%
sequence identity (Fig. 2A). pSR612
contains a division construct in which interval 318 to 350 was divided
into two equivalent intervals by introducing a base substitution
(T334A) (Fig. 2B) into the c
2-21 mm substrate. The base substitution
was introduced by using an appropriate PCR primer. pSR584 contains an
extended construct with recombination substrates of 374 bp instead of
the standard 350 bp (Fig. 2C). The additional 24 bp extend beyond the
3' end of the original 350-bp substrates in pSR424 and were introduced as 5' extensions on reverse PCR primers that anneal to the 3' ends of
c
2 sequences. The 374-bp substrates in the 5' and 3' cassettes were
PCR amplified from template plasmids pSR257 (containing c
2
sequences) and pSR426 (containing c
2-21mm sequences), respectively.
|
2 and c
2-21mm sequences are reversed relative to their
orientations in pSR424. The 5' cassette c
2 substrate was amplified
from pSR257 by using a forward PCR primer with a SpeI site
engineered near the 5' end and a reverse PCR primer with a
BglII site engineered near the 5' end. Ligation of the SpeI/BglII-digested PCR product to
SpeI/BamHI-digested pSR266 yielded a 5' cassette
with c
2 sequences in reverse orientation relative to that in the 5'
cassette of pSR424. To reverse the orientation of the c
2-21 mm
substrate in the 3' cassette, a 350-bp segment was amplified from
pSR426 by using a forward PCR primer with a BglII site
engineered near the 5' end and a reverse PCR primer with an
EcoRI site engineered near the 5' end. Following digestion
with BglII and EcoRI, the PCR product was ligated
to BamHI/EcoRI-digested pSR266, yielding a 3'
cassette with c
2-21mm sequences in reverse orientation relative to
that in the 3' cassette of pSR424.
Yeast strain constructions.
All strains used in this study
were derived from isogenic strains SJR231 (MAT
ade2-101oc his3
200 ura3-Nhe), GCY121 (MAT
ade2-101oc his3
200 ura3-Nhe msh2
msh3
::hisG), and GCY128 (MAT
ade2-101oc his3
200 ura3-Nhe pms1
) (see reference
12) by lithium acetate transformation
(18). pSR424, pSR584, pSR610, or pSR612 was digested with
StuI prior to transformation in order to target integration
to the URA3 locus. Following selection of Ura+
transformants, single-copy integration of the relevant plasmid was
confirmed by PCR or Southern blot analysis.
Generation of independent recombinants.
One-milliliter
cultures were grown nonselectively at 30°C for two days in YEP medium
(1% yeast extract-2% Bacto Peptone) supplemented with 2% glycerol
and 2% ethanol (YEPGE). Cells were harvested, washed once with
H2O, and resuspended in 200 µl of H2O. An
aliquot of 100 µl was plated on SGGE
His selective medium (synthetic
complete medium supplemented with 2% glycerol, 2% galactose, and 2%
ethanol but deficient in histidine) to select for His+
recombinants. Only one colony was taken from each culture in order to
ensure that all recombinants analyzed were of independent origin.
Molecular analysis of recombinants. Genomic DNA was extracted by glass bead lysis (21) from each recombinant and used as a template for PCR amplification. The 5' and 3' recombination products were amplified by using primers homologous to sequences that flank the recombination substrates (see Fig. 1 for the positions of primers). The 5' product was amplified by using primers HIS3-702F (5'-GTTTCTGGACCATATG) and HIS3-765R (5'-GCACTCAACGATTAG), and the 3' recombination product was amplified by using primers HIS3-1751F (5'-GATGGCAAACATGTC) and T3 (5'-TGATGTCGGCGATATAGG). The PCR products were purified by using Qiaquick Spin Columns (Qiagen) and were used as templates for DNA sequencing. Oligonucleotides FAI (5'-ATGGACTAAAGGAGGCT) and T3 were used as sequencing primers for the 5' and 3' recombination products, respectively. All sequencing reactions were carried out with ABI Prizm Dye Terminator Cycle Sequencing Ready Reaction Kits and run on an ABI Prizm 377XL DNA Sequencer (Perkin-Elmer Applied Biosystems).
| |
RESULTS |
|---|
|
|
|---|
The intron-based IR recombination system.
The relevant
features of the intron-based IR recombination system are diagrammed in
Fig. 1 (for a more complete description of the system, see references
12 and 13). A galactose-inducible HIS3 gene containing an artificial intron
(HIS3::intron) was the starting point for all
constructs. 5' or 3' recombination cassettes were constructed by
replacing sequences downstream of the 5' intron splice consensus
element or upstream of the intron TACTAAC element, respectively, with a
fragment derived from c
2 cDNA. 5' cassettes contained the 5' end of
HIS3, the 5' portion of the intron, and a c
2
recombination substrate, whereas 3' cassettes were composed of a
different c
2 recombination substrate, the 3' portion of the intron,
and the 3' end of HIS3. The 5' and 3' cassettes were combined in reverse orientation relative to each other, resulting in
the 3' portion of HIS3::intron being flanked by
c
2 IRs. Following integration of the IR construct at the
URA3 locus in an appropriate his3
strain,
cells are phenotypically His
. Recombination between the
c
2 repeats can reverse the orientation of the intervening region
(referred to below as the invertible segment), thus placing the 5' and
3' parts of the HIS3 gene in the same orientation and
reconstituting a functional intron. Such recombinants are
phenotypically His+ and can be identified on an appropriate
selective medium.
Gene conversion tracts in an MMR-competent strain.
The initial
c
2-derived substrates used to examine gene conversion tracts were
350 bp and 94% identical (c
2 and c
2-21mm). c
2-21mm was
generated from a c
2 plasmid template by low-fidelity PCR. The
c
2-c
2-21mm pair of substrates was chosen for sequencing studies
because the potential mismatches are more randomly distributed than
those in naturally diverged sequences. As illustrated in Fig. 2A, the
mismatches divide the substrates into 21 intervals of perfect identity
ranging in size from 2 to 37 bp. The c
2 substrates were oriented so
that their 3' ends were proximal and their 5' ends were distal to the
intervening invertible segment (orientation 1 in Fig.
3). Following the isolation of a
His+ recombinant, each recombinant c
2 segment was
amplified by PCR using flanking primers (see Fig. 1), and the PCR
products were sequenced individually. A given mismatch was considered
to have undergone a gene conversion event if the same nucleotide was
present in both recombinant c
2 segments; if the recombinant c
2
segments still differed at the position of the original mismatch, then the site was considered not to have undergone gene conversion. A gene
conversion tract encompasses a series of contiguous mismatches.
|
2 repeats [343 bp] minus the 21 mismatched
base pairs), one would expect 4.3% of all endpoints to be in this
interval. For the experimental data, a conversion tract endpoint was
assigned to a given interval if the mismatch defining one side of the
interval was converted but the mismatch defining the other side of the
interval was not. Each continuous conversion tract had two distinct
endpoints, whereas recombinants with no evident conversion tract were
assumed to have two endpoints in the same interval. The expected and
observed distributions of conversion tract endpoints are presented in
Table 1.
|
2 substrates and a
corresponding deficit in the 5' half. The excess is particularly evident in the 3'-most interval; one would predict that only 10% (31 of 322) of all endpoints should be in interval 318 to 350, yet this
interval contained 20% of all endpoints. Because interval 318 to 350 appeared to be particularly "hot" for conversion tract endpoints,
this interval was examined in more detail.
|
Analysis of conversion tract endpoints in interval 318 to 350 by
using a restriction site polymorphism.
A restriction site
polymorphism just upstream of interval 318 to 350 was used to more
accurately quantify the number of conversion tracts that end in this
interval. A mismatch at position 309 establishes a TaiI site
(5'-ACGT-3') in the c
2 substrate but a HinP1I site (5'-GCGC-3') in the c
2-21 mm substrate. Conversion tracts that either start or end in interval 318 to 350 are assumed to include the
mismatch at position 309, and thus both recombination products should
have either a TaiI site or a HinP1I site. The
observation that only 1 of the 62 recombinants sequenced had an
endpoint in interval 309 to 318 validates the use of the polymorphism
at position 309 as a marker for assigning endpoints to interval 318 to
350. Forty-seven additional His+ recombinants were isolated
and were analyzed for the presence or absence of the restriction site
polymorphism. Eighteen (38%) of the recombinants converted the
mismatch at position 309. This value agrees well with the DNA
sequencing results, where 34% (21 of 62 total recombinants sequenced)
of the recombinants had an endpoint(s) in this interval. It should be
noted that the restriction site polymorphism studies indicate whether a
given recombinant has a conversion tract endpoint in interval 318 to
350 but provide no information as to whether the underlying event is
simple or complex. Because of this uncertainty, the percentage of
recombinants with an endpoint(s) in interval 318 to 350, instead of the
percentage of total endpoints in this interval, was calculated for all
constructs.
2 test for this number of endpoints compared to that
expected). There are at least three possible explanations for this
observation. First, this 31-bp interval is the second-longest interval
of perfect identity in the substrates (only interval 244 to 282 is
longer), so the fact that it is a hot spot could simply reflect its
length (i.e., longer intervals might contain a disproportional number of endpoints). Second, this interval is at one end of the substrates and so abuts a region of nonhomology, a location that might create a
bias in favor of the resolution of recombination events. Finally, the
immediate proximity of this interval to the invertible segment may be
important; in both substrates the 3' end of the c
2 sequence is
adjacent to the invertible HIS3::intron segment.
In order to test the above hypotheses, interval 318 to 350 was modified
as shown in Fig. 3, and the effect of each alteration on the frequency of recombinants with an endpoint(s) in the interval was ascertained by
using restriction site polymorphisms.
Division of interval 318 to 350.
A divided construct (Fig. 3)
was created in order to determine whether the length of interval 318 to
350 is important for its hot spot activity. The divided construct was
derived by introducing a T-to-A transversion at position 334 in
c
2-21mm, which creates an additional mismatch between the
recombination substrates and splits interval 318 to 350 into two
smaller intervals of equal length (see Fig. 2B). Conversion of the
TaiI/HinP1I restriction site polymorphism at
position 309 was used to monitor tracts that ended in the 318-to-350
region of the divided construct. Sixty recombinants were examined, and
40% (24 of 60) had an endpoint in interval 318 to 350. This percentage
is similar to that obtained with the undivided orientation 1 construct
(34 and 38% by DNA sequence and restriction site polymorphism
analysis, respectively) and is different from the expected value
(P < 0.01 by the
2 test). Based on the
results obtained with the divided construct, we conclude that the
excess of endpoints in interval 318 to 350 in the undivided orientation
1 construct is not due to the length of uninterrupted identity in this
interval. In addition to dividing interval 318 to 350, the T334A
mutation in the c
2-21mm sequences created a DdeI site
(5'-CTNAG-3'). This new polymorphism was used to further refine the
positions of endpoints within the two halves of interval 318 to 350. Sixteen of the 24 recombinants had an endpoint in interval 318 to 334, 7 had an endpoint in interval 334 to 350, and 1 had an endpoint in each
interval.
Extension of the 3' ends of the substrates.
An extended
construct (Fig. 3) was created in order to test the hypothesis that
interval 318 to 350 is a hot spot because it is at the extreme end of
the substrate and hence borders a region of complete nonhomology. The
original 350-bp substrates were extended at the 3' end by adding two
additional intervals of perfect identity (see Fig. 2C). The first
additional interval (interval 347 to 368) in the extended construct was
20 bp, and the second (interval 368 to 375) was 6 bp. A restriction
site polymorphism was created by mutations at positions 346 and 347 (C346A and C347T), thus creating an EcoRV site
(5'-GATATC-3') in the extended c
2-21mm sequences while maintaining a
BamHI site (5'-GGATCC-3') in the extended c
2 sequences.
The two introduced mismatches separate the previous 318 to 350 interval
(318 to 346 in the extended construct) from the newly added intervals
347 to 368 and 368 to 375. By monitoring the conversion of the
mismatches at positions 309 and 346/347, we were able to determine how
many conversion tracts ended either in interval 318 to 346 or in
interval 347 to 375. Among 49 recombinants analyzed, 17 (35%) had an
endpoint in interval 318 to 346. This percentage is very similar to the proportion of orientation 1 recombinants with endpoints in interval 318 to 350 and is significantly different from the expected value (P = 0.01 by the
2 test). Interestingly,
the two new intervals in the extended construct also contained a
disproportional number of endpoints. Because the new intervals contain
7.6% (26 of 344) of the nucleotide identity in the extended
substrates, approximately 15% of recombinants would be expected to
contain an endpoint in the extended region. Thirteen of the 49 recombinants (27%), however, had an endpoint in the newly added
intervals, which is significantly more than expected (P < 0.05 by the
2 test). Based on the results with the
extended substrates, it appears that an interval needs only to be near,
rather than at, the 3' end of the c
2 substrate in order to contain
an excess of conversion tract endpoints. This result is consistent with the general observation (Fig. 4A) that there is an excess of endpoints in the 3' halves of the substrates and a deficit of endpoints in the 5'
halves. This "gradient" either could be related to the lower
density of mismatches in the 3' halves of the substrates or could
reflect the proximity of the 3' ends of the substrates to the
invertible segment. These two possibilities were distinguished by
reversing the orientations of the c
2 substrates relative to the
invertible HIS3::intron sequences.
Reorientation of the substrates relative to the invertible
segment.
The orientation of each of the c
2 substrates was
reversed relative to the HIS3::intron sequences,
thus placing the original 3' substrate ends (with an excess of
endpoints) distal to the invertible segment and the original 5' ends
(with a deficit of endpoints) adjacent to the invertible segment.
Substrates in the reverse orientation will be referred to as being in
orientation 2 (see Fig. 3). As described above, the proportion of
recombinants with a conversion tract endpoint in interval 318 to 350 (note that the same nucleotide receives the same coordinate for
orientations 1 and 2) was analyzed by using the
TaiI/HinP1I restriction site polymorphism. Only
23% (11 of 48; P > 0.5 by the
2 test
for this number of endpoints compared to that expected) of the
orientation 2 recombinants had an endpoint in interval 318 to 350, compared to 34 to 40% of recombinants with an endpoint in this
interval with the orientation 1 construct, the divided construct, and
the extended construct. This result suggested that altering the
orientation of the recombination substrates might have reversed the
gradient of conversion tract endpoints evident with the orientation 1 substrates. To examine this further, the first 26 recombinants derived
by using the orientation 2 substrates were subjected to DNA sequence
analysis in order to determine the precise positions of all conversion
tract endpoints. Twenty-two recombinants had continuous conversion
tracts, two had complex conversion tracts, and two had no detectable
conversion tract. This distribution of recombinant classes was the same
as that obtained with the orientation 1 substrates (50 continuous
tracts, 6 complex tracts, and 6 simple crossovers; P > 0.90 by the
2 contingency test). The distribution of
conversion tract endpoints for the orientation 2 substrates is given in
Table 1 and is compared graphically to the expected distribution in
Fig. 4B. Whereas recombinants derived from the orientation 1 c
2
substrates had an excess of endpoints near the 3' ends of the
substrates (Fig. 4A), the orientation 2 substrates yielded recombinants
with a clear excess of endpoints in the 5' halves of the c
2
sequences. These data suggest that the distribution of endpoints is
determined primarily by the relative proximity of an interval to the
invertible HIS3::intron segment located between
the substrates rather than by interval size or sequence. In other
words, intervals close to the invertible segment are more likely to
contain a conversion tract endpoint than are intervals that are farther
away from the invertible segment.
Conversion tract endpoints in MMR-defective cells. The yeast MMR system exerts a strong antirecombination effect on the 94%-identical substrates used in the conversion tract analysis above (13). Therefore, we examined gene conversion tracts in cells defective in mismatch binding activity (an msh2 msh3 mutant) in order to ascertain whether the MMR system impacts the nature of recombination intermediates. Because there is no gene conversion via MMR of heteroduplex DNA in MMR-defective cells, any heteroduplex formed during recombination will be segregated at the next round of DNA replication. Replication of the unrepaired donor DNA thus will produce the equivalent of a gene conversion tract.
Sixty-two His+ recombinants derived from an msh2 msh3 strain containing the orientation 1 substrates were sequenced to estimate the extent of heteroduplex formation. Forty of the 62 recombinants had a single continuous conversion tract, 12 had no mismatches converted, and 10 were classified as complex conversions. This class distribution was the same as that observed in the MMR-competent cells (P > 0.30 by the
2
contingency test). The distribution of conversion tract endpoints is
presented in Table 1, and this distribution is compared to the expected
distribution in Fig. 4C. In contrast to the presence of excess
endpoints at the 3' ends of the orientation 1 substrates in wild-type
cells, there was no apparent clustering of endpoints in msh2
msh3 cells. A similar loss of endpoint clustering was observed
when the orientation 2 substrates were analyzed in an msh2
msh3 background (Fig. 4D). The effect of Pms1p on conversion tract
endpoints also was examined, and the data are presented in Table 1 and
Fig. 4E. As observed in the msh2 msh3 mutant background, no
clear endpoint clustering was evident in the pms1 mutant.
These results suggest a causative role for the yeast MMR machinery in establishing the conversion tract endpoint clustering near the invertible segment that was observed with both the orientation 1 and
the orientation 2 c
2 substrates in wild-type cells.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, an intron-based recombination assay system has been used to generate recombinants between a pair of 94%-identical substrates oriented as IRs (see Fig. 1). The IR substrates flank the 3' end of an intron-containing HIS3 gene, which is in reverse orientation relative to the 5' end of the gene. Reorientation of the 3' HIS3::intron segment via recombination involving the flanking IRs reconstitutes a functional HIS3 gene, and such events can be identified as His+ colonies on histidine-deficient medium.
Although reorientation or flipping of a segment of DNA is generally
considered to result from intrachromatid crossing over between flanking
IRs (Fig. 5A), a sister chromatid gene
conversion event also can flip the region between IRs (42).
In sister chromatid gene conversion (Fig. 5B), one of the chromatids
loops around and pairs with the sister; the substrate upstream of the
invertible segment on one chromatid pairs with the downstream substrate
on the sister chromatid, and the substrate downstream of the invertible segment likewise pairs with the upstream substrate on the sister. The
invertible segment is thus flanked by sister-sister pairings, each of
which involves diverged rather than identical substrates. Gene
conversion events that initiate in the paired sequences on one side of
the invertible segment, extend through the invertible segment, and
terminate in the paired sequences on the other side will flip the
invertible segment. It should be noted that neither intrachromatid gene
conversion nor sister chromatid crossing over will yield
His+ recombinants. Intrachromatid gene conversion does not
reorient the invertible segment, so recombinants remain
His
; sister chromatid crossing over gives rise to
acentric and dicentric recombinant chromosomes, resulting in inviable
progeny.
|
Distributions of conversion tract endpoints in a wild-type strain. DNA sequence analysis of both products derived from individual recombination events allowed for the determination of conversion tract endpoints. In the discussion that follows, it is assumed that conversion tracts are an accurate representation of the extent of heteroduplex DNA present in recombination intermediates. We recognize the formal possibility, however, that conversion tract endpoints may not necessarily correspond to positions where recombination events begin and end. At least in MMR-competent cells, endpoints could correspond to repair borders. We also note that the repair of heteroduplex DNA in mitosis is not likely to be 100% efficient (41), so some of the conversion tracts in MMR-competent cells may arise via replicative resolution of heteroduplex intermediates, which is the likely mechanism for generating conversion tracts in MMR-defective cells. Regardless of the mechanism for generating a conversion tract, however, this mechanism presumably operates after the completion of heteroduplex DNA formation and thus should not affect the extent of heteroduplex formed. In determining conversion tract parameters, only the no-conversion and continuous, asymmetric conversion tract classes, which together accounted for 90% of His+ recombinants, were considered. The relative rarity of symmetric or discontinuous conversion tracts is in general agreement with mitotic data obtained in previous studies (2, 49).
The most striking feature of the conversion tracts derived from the orientation 1 c
2 substrates is an excess of endpoints at the 3' ends
of the substrates (Fig. 4A). Because the 3' halves of the c
2
substrates contain fewer mismatches (and hence longer stretches of
perfect identity) than the 5' halves (see Fig. 2A), the biased endpoint
distribution could be directly related to mismatch density. This
possibility was addressed by reversing the orientations of the
recombination substrates relative to the HIS3::intron segments (orientation 2 substrates).
If mismatch density is the relevant factor, reversing the orientation
of the substrates should not affect the distribution of endpoints; the 3' half should still contain an excess of endpoints, and the 5' half
should still contain a deficit. We observed, however, that the
endpoint clustering was reversed with the orientation 2 substrates, so
that the end with the greatest mismatch density contained the largest
number of endpoints (Fig. 4B). This result indicates that the endpoint
distribution is determined primarily by the orientation of the
substrates relative to the intervening invertible segment, such that
the identity intervals containing the excess of endpoints are those
intervals closest to the invertible segment. As will be discussed in
more detail below, we believe that the endpoint distributions are
readily explained by a sister chromatid conversion model but are
difficult to rationalize if one assumes that most events are the result
of intrachromatid crossover.
The distribution of endpoints relative to the lengths of homology
blocks also was analyzed in order to determine whether the distribution
of conversion tract endpoints is proportional to the length of the
homology intervals or whether there is a bias for endpoints to occur in
the longer homology blocks. This analysis indicated that endpoints are
randomly distributed with respect to the lengths of homology blocks
(data not shown). A similar conclusion was reached by Porter et al.
(35).
Distributions of conversion tract endpoints in MMR-defective
strains.
Conversion tract endpoints were determined in
MMR-defective strains in order to ascertain whether endpoint
distributions are influenced by the yeast MMR machinery. The clear
endpoint clustering evident with the c
2 substrates in either
orientation 1 (Fig. 4A) or orientation 2 (Fig. 4B) was abolished in an
msh2 msh3 background (Fig. 4C and D). Similarly, in a
pms1 mutant (Fig. 4E) there was no indication of the
prominent endpoint clustering that was evident in wild-type cells. The
data presented in Fig. 4 thus demonstrate that the biased endpoint
distributions evident in wild-type cells are dependent on a functional
MMR system. As will be elaborated further below, we speculate that the
alteration of conversion tract endpoints by MMR proteins is related to
the documented antirecombination activity of these proteins.
Intrachromatid crossover versus sister chromatid conversion. As shown in Fig. 6, estimates of conversion tract lengths are very different for intrachromatid crossovers and sister chromatid conversion events that have the same endpoints. In principle, an intrachromatid crossover can be distinguished from sister chromatid conversion if the recombination intermediate can be captured and analyzed physically or if the timing of the recombination event in the cell cycle (G1 versus G2) can be determined. Given the low frequency with which our diverged substrates recombine, however, neither approach is feasible at present. As argued below, however, we believe that the majority of the His+ recombinants detected by our assay system occur via sister chromatid conversion rather than via intrachromatid crossover.
|
2 analysis). Although the data obtained for
MMR-defective cells would be consistent with the formation of
predominantly symmetric heteroduplex intermediates (both replication
products of which should have conversion tracts), symmetric
heteroduplexes generally are assumed to be rare relative to asymmetric
heteroduplexes in yeast. The extensive analysis of IR recombination
carried out by Ahn and Livingston (2) indicates that 90% of
mitotic conversion tracts are indeed asymmetric.
|
orientation, whereas the strand donated from the
sister will have the HIS3::intron segment in the
reverse, His+ orientation. In the absence of MMR, only the
strand containing the donated DNA will give rise to a daughter
chromosome that carries a His+ allele. Since the donated
DNA must contain part of the IRs that flank the invertible
HIS3::intron segment, flanking IR segments always will be coconverted along with the invertible segment. In other
words, the selection of the donor-derived invertible segment ensures
the inheritance of flanking information from the donor as well in all
the His+ recombinants. One thus would predict that gene
conversion events should be the predominant events, and the data
presented in Results are consistent with this prediction. According to
the sister chromatid conversion model, recombinants with no detectable
gene conversion tract correspond to gene conversion events that have
endpoints in the same identity interval on both sides of the invertible segment.
In addition to the fates of asymmetric heteroduplex DNA intermediates
in MMR-defective cells, there are two other observations that are
more readily explained by the sister chromatid conversion model than by
the intrachromatid crossover model. First, the sister chromatid
conversion model can account for the clustering of conversion tract
endpoints observed in wild-type cells. Because reorientation via gene
conversion of the invertible HIS3::intron
sequences located between the IR substrates is selected by the system,
each successful recombination event must have one endpoint within
substrates on one side of the invertible segment and the other endpoint
within substrates on the other side. The closer a mismatch is to the invertible segment, the higher the probability that it will be included
in a heteroduplex intermediate. The net result is a conversion gradient
that falls off on either side of the selected site, which is the
invertible segment in this case. It should be noted that a similar
recombination gradient was observed by Willis and Klein (54), using a system in which a kanamycin resistance gene
(Kanr) was flanked by 360-bp IRs. By using a small number
of restriction site polymorphisms, it was demonstrated that the
presumptive crossover events preferentially occurred proximal to the
invertible segment. As explained above, a clustering of endpoints close
to an invertible segment is exactly what one would predict if the
underlying mechanism involves sister chromatid conversion rather than
intrachromatid crossover.
A second observation that can be more readily explained by the sister
chromatid conversion model concerns the inhibitory effect of MMR
proteins on recombination between perfectly identical IR sequences.
Using the same intron-based system as that used in this study, we have
consistently observed a perplexing two- to threefold stimulation of
recombination between identical substrates in msh2 msh3
strains relative to wild-type strains (12, 13). Based on the
assumption that recombination occurred exclusively via intrachromatid
crossover, we suggested that the MMR machinery might be detecting the
extension of heteroduplex DNA into flanking nonhomologous sequences.
According to the sister chromatid conversion model,
heteroduplex DNA that covers the invertible
HIS3::intron region will be at least transiently
unpaired (a completely paired inversion loop could form, in principle,
when the heteroduplex has extended across the entire region), and this
large heterology could be the intermediate recognized by MMR proteins.
We suggest that the junction between duplex DNA and unpaired single
strands might provide an appropriate target for the Rad1p/Rad10p
nuclease, which acts in conjunction with Msh2p and Msh3p to remove
nonhomologous ends during recombination (47). Consistent
with this possibility, recombination rates between identical sequences
are also elevated in a rad1 mutant, but not in an
msh6 or pms1 mutant (4a).
One potential problem with the sister chromatid conversion model is
that it involves the extension of heteroduplex DNA through a large
region of heterology. In the HIS3::intron system
used here, the distance between the IR substrates is approximately 1.1 kb. Available evidence indicates that heteroduplex extension through a
region this size should not present an obstacle for the yeast
recombination machinery. Mitotic gene conversion of lys2
deletions in the 1- to 2-kb range has been reported (8), as
well as conversion of a 6-kb Ty element inserted within the URA3 locus (50).
The sister chromatid conversion model applies not only to our system
but also to other recombination assay systems that use IRs. The general
assumption that the reorientation of the region between IRs is
diagnostic of an intrachromatid crossover is likely to be incorrect.
The possibility of sister chromatid conversion adds additional
complexity to the types of recombination events that can occur between
IRs and may alter interpretations of existing data. The majority of
recombination within the yeast rDNA array also has been shown to
correspond to gene conversion rather than to crossover events
(17), so one might argue that crossing over is generally
very rare in mitosis. It should be noted, however, that ectopic
recombination events involving nonhomologous chromosomes frequently
generate reciprocal translocations (25, 27).
Lengths of conversion tracts in wild-type cells.
We believe
that our data are most consistent with the sister chromatid conversion
model, which involves coconversion of sequences flanking the invertible
HIS3::intron segment. The extent of a conversion
tract thus becomes the sum of two conversion tracts, one on either side
of the invertible segment. Furthermore, those events with no conversion
tract would not have two endpoints in the same interval but rather
would have an endpoint in each of the relevant identical intervals that
flank the invertible segment. For each recombinant examined, DNA
sequencing data were used to calculate minimal, maximal, and average
tract lengths. Table 2 presents the
mathematical mean values for the minimal, maximal, and average tract
lengths, as well as the mean number of mismatches included in
conversion tracts. With the c
2 substrates in orientation 1, the mean
of the average conversion tract lengths was 275 bp in wild-type cells,
and tracts included an average of 14.4 mismatches. Very similar results
were obtained with the orientation 2 c
2 substrates, where the mean
of the average conversion tract lengths was 230 bp and tracts included
an average of 14.2 mismatches. The mean of the average tract lengths
(as well as the means of the minimal and maximal lengths) was slightly
larger with the orientation 1 substrates than with the orientation 2 substrates, although the mean number of mismatches converted was the
same. This likely reflects the fact that the orientation 1 substrates had the end with the lower mismatch density (the 3' end) closest to the
invertible segment (whose conversion was selected for), whereas the
orientation 2 substrates had the end with the higher mismatch density
closest to the invertible segment. The relevant parameter for
regulating heteroduplex length in MMR-competent cells thus appears to
be the number of mismatches traversed. An examination of the
distribution of conversion tract endpoints for the orientation 1 and
orientation 2 substrates (Fig. 4A and B, respectively) is consistent
with this interpretation. As noted previously, there is an excess of
endpoints proximal to the invertible segment for both substrate
orientations. If 14 total mismatches are included in heteroduplex
intermediates, then conversion tracts should include an average of 7 mismatches on each side of the invertible segment and the transition
from an excess to a deficit of endpoints should occur approximately 7 mismatches from the invertible segment. As predicted, the position of
the shift from an excess of endpoints to a deficit of endpoints occurs
seven and eight mismatches away from the invertible segment for the orientation 1 and orientation 2 substrates, respectively.
|
Lengths of conversion tracts in MMR-defective cells. Gene conversion tracts presumably arise via repair of heteroduplex DNA and replicative segregation of heteroduplex DNA, respectively, in wild-type and MMR-defective cells. Although they are generated in mechanistically distinct manners, we suggest that conversion tracts generated in the presence or absence of MMR should nevertheless be an accurate reflection of the underlying heteroduplex recombination intermediate. Measuring gene conversion tracts may not be the ideal way to obtain estimates of heteroduplex DNA in mitotically dividing cells, but it is presently the only way to do so.
Elimination of Msh2p and Msh3p had the effect of lengthening gene conversion tracts approximately 50% (Table 2). For the c
2 repeats
in orientation 1, the mean of the average tract lengths was 385 bp and
tracts included a mean of 21.2 mismatches (versus 275 bp and 14.4 mismatches in wild-type cells). For the orientation 2 c
2 repeats,
the mean of the average conversion tract lengths was 339 bp and tracts
included a mean of 21.5 mismatches (versus 230 bp and 14.2 mismatches
in wild-type cells). The differences in tract length between wild-type
and MMR-defective cells are highly significant (P < 0.005 by Student's t test). Data obtained by Negritto et
al. (32) also are consistent with conversion tracts being
longer in MMR-defective cells than in wild-type cells. Their study
utilized the 83%-identical yeast SAM1 and SAM2
genes, and it was noted that coconversion of two restriction site
polymorphisms with a selected site was more common in msh2
cells than in wild-type cells.
In recombination assays involving diverged sequences, Msh2p
exerts a stronger antirecombination activity than does Pms1p (12, 44). With the 94%-identical substrates used in this study,
elimination of MSH2 stimulates mitotic recombination
approximately 40-fold, whereas elimination of PMS1
stimulates recombination only 15-fold (29a). The mean of the
average conversion tract lengths in a pms1 mutant was 327 bp, which was between the lengths observed in wild-type and msh2
msh3 strains (275 and 385 bp, respectively). Similarly, the
mean number of mismatches converted in a pms1 mutant (17.6) was between the numbers observed in wild-type and msh2 msh3 strains (14.4 and 21.2, respectively). Although the
differences between pms1
strain conversion tracts and
those of either the wild-type or msh2
strain are not
statistically significant (0.14 < P < 0.18 by
Student's t test), we suggest that mismatches have a
greater impact on heteroduplex length when Pms1p is present, which is
consistent with more-efficient recognition of mismatches by the yeast
MutS homologs in the presence of MutL homologs (19).
Relation of conversion tract lengths and endpoints to the antirecombination activity of MMR proteins. If one assumes that gene conversion tracts are an accurate representation of the extent of heteroduplex DNA formed in the presence of MMR proteins, then our data indicate that MMR proteins regulate the formation of heteroduplex DNA during mitotic recombination. Specifically, heteroduplex tracts are shorter and cover fewer mismatches in wild-type cells than in MMR-defective cells (Table 2). The tract shortening can account for the biased distribution of conversion tract endpoints observed in wild-type cells, where endpoints were clustered at the substrate end closest to the invertible segment (Fig. 4). To our knowledge, no other model could account for such an MMR-dependent clustering of conversion tract endpoints. The idea that MMR proteins might regulate heteroduplex formation when mismatches are present is not a new one (see references 10 and 37), but exactly how this might occur is not clear. MMR proteins could monitor the fidelity of the initial strand exchange reaction, they could regulate the extension of heteroduplex DNA, or they could bias how recombination intermediates are resolved. It also is possible that these proteins could act at more than one step. Recent data from mammalian cells suggest that the initiation, but not the extension, of heteroduplex formation is blocked by mismatches, although the involvement of the MMR machinery was not examined (56). Based on studies of meiotic gene conversion polarity gradients, Alani et al. (3) suggested that MMR proteins specifically block the extension of symmetric heteroduplex intermediates and should, therefore, bias resolution in favor of noncrossovers (see also reference 23). The relevance of the meiotic studies to the data reported here, however, is unclear, since our assay involves recombination between highly mismatched substrates in mitosis.
Regardless of the precise mechanistic explanation, our data indicate that MMR proteins modulate the structures of mitotic heteroduplex recombination intermediates. We suggest that the MMR-associated conversion tract shortening reflects a blockage of heteroduplex extension through mismatched regions, and we think it likely that MMR proteins are associated with the hypothetical yeast recombinasome. A critical question that has not been addressed is how the observed MMR-dependent shortening of c
2 gene conversion tracts relates to the
potent antirecombination activity of MMR proteins reported previously
(13). Specifically, can a 50% shortening of conversion
tracts by MMR proteins directly account for the observed 50-fold
inhibition of recombination? We think not, and we propose the following
model to relate the two observations. We suggest that the shortening of
conversion tracts by the MMR machinery reflects the role of these
proteins in impeding the extension of heteroduplex DNA through
mismatched regions. One plausible scenario is that the MMR-associated
slowing of heteroduplex extension triggers a helicase-catalyzed
reversal of heteroduplex formation, which would be analogous to reverse
branch migration. We note that a similar model was proposed by Zahrt
and Maloy (57) to explain data obtained in transductions
between closely related Salmonella species. According to
such a heteroduplex rejection model, there would be competition between
extension and removal of heteroduplex DNA, and under normal
circumstances, the forward reaction would be highly favored. In the
presence of mismatches, however, MMR proteins would impede forward
progress, and the reverse reaction would be favored. If MMR proteins
are directly associated with the recombination machinery, then it is
not difficult to imagine that binding to mismatches in newly formed
heteroduplex DNA as the machinery progresses might slow down the
forward reaction. The few recombinants detected in MMR-competent cells
thus provide a snapshot of the MMR-imposed barrier to heteroduplex
extension and represent those few heteroduplexes that survive long
enough to produce mature recombinants. The confirmation of this model will likely depend on the further development of in vitro reactions that allow the progress of recombination between mismatched sequences to be directly monitored.
| |
ACKNOWLEDGMENTS |
|---|
We are indebted to Lorraine Symington for originally pointing out sister chromatid conversion as an alternative to intrachromatid crossover, and we acknowledge the excellent technical assistance of Neal Graber. We thank Gray Crouse and members of the S.J.-R. lab for helpful comments on the manuscript. We also thank Hannah Klein and another, anonymous reviewer for constructive criticisms of the manuscript.
This work was supported by National Institutes of Health (NIH) grant GM38464 (to S.J.-R.). W.C. was supported in part by the Graduate Division of Biological and Biomedical Sciences and by an NIH Medical Scientist Training grant (Emory University).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biology, Emory University, 1510 Clifton Rd., Atlanta, GA 30322. Phone: (404) 727-6312. Fax: (404) 727-2880. E-mail: jinks{at}biology.emory.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abdulkarim, F., and D. Hughes. 1996. Homologous recombination between the tuf genes of Salmonella typhimurium. J. Mol. Biol. 260:506-522[Medline]. |
| 2. |
Ahn, B.-Y., and D. M. Livingston.
1986.
Mitotic gene conversion lengths, coconversion patterns, and the incidence of reciprocal recombination in a Saccharomyces cerevisiae plasmid system.
Mol. Cell. Biol.
6:3685-3693 |
| 3. | Alani, E., R. A. G. Reenan, and R. D. Kolodner. 1994. Interaction between mismatch repair and genetic recombination in Saccharomyces cerevisiae. Genetics 137:19-39[Abstract]. |
| 4. | Bailis, A. M., and R. Rothstein. 1990. A defect in mismatch repair in Saccharomyces cerevisiae stimulates ectopic recombination between homeologous genes by an excision repair-dependent process. Genetics 126:535-547[Abstract]. |
| 4a. | Bayliss, A., M. Hendrix, J. McDougal, S. Jinks-Robertson, and G. Crouse. Unpublished data. |
| 5. |
Borts, R. H., and J. E. Haber.
1987.
Meiotic recombination in yeast: alteration by multiple heterozygosities.
Science
237:1459-1465 |
| 6. | Borts, R. H., W.-Y. Leung, W. Kramer, B. Kramer, M. Williamson, S. Fogel, and J. E. Haber. 1990. Mismatch repair-induced meiotic recombination requires PMS1 gene product. Genetics 124:573-584[Abstract]. |
| 7. | Chambers, S. R., N. Hunter, E. J. Louis, and R. H. Borts. 1996. The mismatch repair system reduces meiotic homeologous recombination and stimulates recombination-dependent chromosome loss. Mol. Cell. Biol. 16:6110-6120[Abstract]. |
| 8. | Chernoff, Y. O., O. V. Kidgotko, O. Demberelijn, I. L. Luchnikova, S. P. Soldatov, V. M. Glazer, and D. A. Gordenin. 1984. Mitotic intragenic recombination in the yeast Saccharomyces: marker-effects on conversion and reciprocity of recombination. Curr. Genet. 9:31-374. |
| 9. | Ciotta, C., S. Ceccotti, G. Aquilina, O. Humbert, F. Palombo, J. Jiricny, and M. Bignami. 1998. Increased somatic recombination in methylation-tolerant human cells with defective DNA mismatch repair. J. Mol. Biol. 276:705-719[Medline]. |
| 10. |
Claverys, J.-P., and S. A. Lacks.
1986.
Heteroduplex deoxyribonucleic acid base mismatch repair in bacteria.
Microbiol. Rev.
50:133-165 |
| 11. | Crouse, G. F. 1998. Mismatch repair systems in Saccharomyces cerevisiae, p. 411-448. In J. A. Nickoloff, and M. F. Hoekstra (ed.), DNA damage and repair, vol. 1. DNA repair in prokaryotes and lower eukaryotes. Humana Press, Totowa, N.J. |
| 12. | Datta, A., A. Adjiri, L. New, G. F. Crouse, and S. Jinks-Robertson. 1996. Mitotic crossovers between diverged sequences are regulated by mismatch repair proteins in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1085-1093[Abstract]. |
| 13. |
Datta, A.,
M. Hendrix,
M. Lipsitch, and S. Jinks-Robertson.
1997.
Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast.
Proc. Natl. Acad. Sci. USA
94:9757-9762 |
| 14. | de Wind, N., M. Dekker, A. Berns, M. Radman, and H. te Riele. 1995. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82:321-330[Medline]. |
| 15. |
Elliott, B.,
C. Richardson,
J. Winderbaum,
J. A. Nickoloff, and M. Jasin.
1998.
Gene conversion tracts from double-strand break repair in mammalian cells.
Mol. Cell. Biol.
18:93-101 |
| 16. |
Feinstein, S. I., and K. B. Low.
1986.
Hyper-recombining recipient strains in bacterial conjugation.
Genetics
113:13-33 |
| 17. | Gangloff, S., H. Zou, and R. |